Wikisage, the free encyclopedia of the second generation, is digital heritage
Mepolizumab: Difference between revisions
Jump to navigation
Jump to search
(Created page with "'''Mepolizumab''' is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction i...") |
(fix) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Mepolizumab''' is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction in allergic symptoms of asthma and hypereosinophilic síndromes <ref>[https://www.ncbi.nlm.nih.gov/books/NBK548052/ LiberTox: Clinical and Research Information on Drug-Induced Liver Injury] <nowiki>[Internet]</nowiki>.</ref> | '''Mepolizumab''' is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction in allergic symptoms of asthma and hypereosinophilic síndromes <ref>[https://www.ncbi.nlm.nih.gov/books/NBK548052/ LiberTox: Clinical and Research Information on Drug-Induced Liver Injury] <nowiki>[Internet]</nowiki>.</ref> | ||
==Links== | ==Links== | ||
[[Churg-Strauss_syndrome|Churg Strauss syndrome]] | |||
[https://karmel.miraheze.org/wiki/Mepolizumab karmel(miraheze):Mepolizumab] | [https://karmel.miraheze.org/wiki/Mepolizumab karmel(miraheze):Mepolizumab] | ||
{{Wikidata|Q3306175}} | |||
{{refs}} | |||
Latest revision as of 16:05, 23 January 2020
Mepolizumab is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction in allergic symptoms of asthma and hypereosinophilic síndromes [1]
Links
| References: |